51463-15-1 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
3(2H)-Isoquinolinone, 6-fluorois used as a building block or precursor in the synthesis of various compounds with biological activity. Its structural similarity to other bioactive molecules and the unique properties conferred by its fluorinated nature make it a valuable component in the development of new therapeutic agents.
Used in Medicinal Chemistry:
3(2H)-Isoquinolinone, 6-fluorois utilized in medicinal chemistry for the design and synthesis of novel compounds with potential therapeutic applications. Its unique structural features and interactions with biological systems can contribute to the discovery of new drugs with improved efficacy and selectivity.
Used in Bioactive Compound Synthesis:
3(2H)-Isoquinolinone, 6-fluorois employed as a key intermediate in the synthesis of bioactive compounds with potential applications in various therapeutic areas. Its fluorinated nature can enhance the pharmacokinetic and pharmacodynamic properties of the resulting compounds, leading to the development of more effective and safer drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 51463-15-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,4,6 and 3 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 51463-15:
(7*5)+(6*1)+(5*4)+(4*6)+(3*3)+(2*1)+(1*5)=101
101 % 10 = 1
So 51463-15-1 is a valid CAS Registry Number.
51463-15-1Relevant academic research and scientific papers
AMINOISOXAZOLINE COMPOUNDS AS AGONISTS OF ALPHA7-NICOTINIC ACETYLCHOLINE RECEPTORS
-
Paragraph 00357; 00358, (2017/05/19)
The present invention relates to novel aminoisoxazoline compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.
